• Subscribe
    e

    Xconomy’s Digital Events →

    ▾
  • Xconomy National

  • Our
    Regions
    • National ›
      • Sanofi, Pfizer & Bristol Drugs Among the 12 Approvals to Look Out for in Q4
        Sanofi, Pfizer & Bristol Drugs Among the 12 Approvals to Look Out for in Q4
      View More in National ›
    • Europe ›
      • FDA Panel Vote Weighs in Favor of Alkermes Psych Drug, With Caveats
        FDA Panel Vote Weighs in Favor of Alkermes Psych Drug, With Caveats
      View More in Europe ›
    • Boston ›
      • Vertex Stops Test of Rare Disease Drug, Dimming Pipeline Prospects
        Vertex Stops Test of Rare Disease Drug, Dimming Pipeline Prospects
      View More in Boston ›
    • Boulder/Denver ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Boulder/Denver ›
    • Detroit/Ann Arbor ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Detroit/Ann Arbor ›
    • Indiana ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Indiana ›
    • New York ›
      • “Opioid Stacking” Concerns Lead FDA to Reject Avenue Therapeutics Drug
        “Opioid Stacking” Concerns Lead FDA to Reject Avenue Therapeutics Drug
      View More in New York ›
    • Philadelphia ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Philadelphia ›
    • Raleigh-Durham ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Raleigh-Durham ›
    • San Diego ›
      • Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma
        Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma
      View More in San Diego ›
    • San Francisco ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in San Francisco ›
    • Seattle ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Seattle ›
    • Texas ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Texas ›
    • Wisconsin ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Wisconsin ›
  • Topic
    Channels
    • Life Sciences›
        View More in Life Sciences ›
      • Healthtech›
          View More in Healthtech ›
        • Robotics and A.I.›
            View More in Robotics and A.I. ›
          • Startups›
              View More in Startups ›
          • Our
            Events
            • All Xconomy Events ›
          • Xconomy
            Insight

          “raj-singh” Archives

          in
          Entry Author Date Location
          Nonprofit LifeNet Acquires Biotech With San Antonio Presence David Holley 11/04/16 Texas
          Seattle Week in Review: To Asia via Puyallup, Space via Kent Benjamin Romano 03/11/16 National
          Seattle Week in Review: Why We’re Great, Code Schools, Health IT, Art in Space Benjamin Romano 03/04/16 Seattle
          Roundup: JEMS, MSU Bootcamp, FordDirect, Start Garden, U-M Solar Car Sarah Schmid Stevenson 08/04/14 Detroit Ann Arbor
          Wellntel Aims to Sprout Groundwater Info Market With Sonar Device Jeff Bauter Engel 06/26/14 Wisconsin
          The Future of Work, Plus or Minus E-mail Wade Roush 06/16/14 San Francisco
          Travel Startup TripIt Acquired by Seattle’s Concur for As Much As $120 Million; Handsome Exit for Azure Capital Wade Roush 01/13/11 San Francisco
          Corensic, Concur, and Teradici: A Mini Tech Deals Roundup Gregory T. Huang 01/13/11 Seattle
          Concur’s Raj Singh on the Emerging Mobile Scene and Where He Sees the Company Going in the Next Five Years (Part 2) Thea Chard 07/09/10 Seattle
          Concur Co-founder Raj Singh on How Surviving the Dotcom Bust Shaped the Company Culture and How Mobile Has Changed its Course (Part 1) Thea Chard 07/08/10 Seattle
          Page 1 of 1

          Underwriters and Partners

          Xconomy Insight
          • Navigating Challenges & Advancing Clinical Development: A Toolkit for Emerging Biotechs

            Sponsored · Whitepaper

            Navigating Challenges & Advancing Clinical Development: A Toolkit for Emerging Biotechs

            How incorporating more virtual/hybrid trials and decentralized research into clinical development can better integrate healthcare into patients’ real lives and accelerate approval of new medications.

            Medpace
          • The Importance of Early Key Opinion Leader Outreach in the Biologics & Biosimilars Marketplace

            Sponsored · Whitepaper

            The Importance of Early Key Opinion Leader Outreach in the Biologics & Biosimilars Marketplace

            Acknowledging various stakeholder networks and regulatory environment variances is essential to uncover the right decision-makers in support of biologics or biosimilars

            IBM Watson
          • Biotech Startups: How to Succeed in a COVID-19 World

            Xconomy Insight · Special Report

            Biotech Startups: How to Succeed in a COVID-19 World

            Industry experts explain what it takes to launch a new biotech company

          Xconomy on Demand

          We offer a number of ways to subscribe for free!

          Subscribe Now
          Informa Connect Logo Informa Connect Logo
          • Home
          • Privacy Policy
          • Security Disclosures
          • About
          • Contact Us
          • Archives
          • Advertise
          • Subscribe for Free

          © 2007-2022, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.